✦ LIBER ✦

P1-383 Cerebrolysin-efficacy and safety in moderate to moderately severe Alzheimer's disease: subgroup analysis of a randomized, double-blind, placebo-controlled trial

✍ Scribed by Herbert Moessler; Antòn X. Álvarez; Ramón Cacabelos

Book ID: 117413256
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 160 KB
Volume: 25
Category: Article
ISSN: 0197-4580
DOI: 10.1016/s0197-4580(04)80695-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of Cerebrolysin in m

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

✍ X. A. Alvarez; R. Cacabelos; C. Sampedro; M. Aleixandre; C. Linares; E. Granizo; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Efficacy and safety of donepezil in pati

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

✍ Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R. Ie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

## Abstract ## Background There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD). The efficacy and safety of donepezil were evaluated in __post hoc__ analyses of a subgroup of patients with more severe AD (standardized Mi

Combined treatment with cerebrolysin and

Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double-blind, randomized clinical trial

✍ Anton Alvarez; Ramon Cacabelos; Manuel Aleixandre; Carlos Linares; Elias Granizo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A long-term, double-blind, placebo-contr

A long-term, double-blind, placebo-controlled efficacy and safety study of nicergoline in patients with mild to moderate Alzheimer's disease

✍ L. Amaducci; K. Maurer; B. Winblad; R. Dom; R. Bullock; L. Bonura; A. Battaglia; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Safety and efficacy of a galantamine/mem

Safety and efficacy of a galantamine/memantine combination in mild to moderate Alzheimer's disease - randomized controlled trial

✍ Oliver Peters; Wolfgang Maier; Christian Luckhaus; Johannes Kornhuber; Johannes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Safety and efficacy of galantamine (Remi

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

✍ Alistair Burns; Roberto Bernabei; Roger Bullock; Alfonso J Cruz Jentoft; Lutz Fr 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 226 KB